Public signalCompany raiseAuto-indexed · Unverified

IMMUNIC, INC. raised $80.0M

IMMUNIC, INC.· NEW YORK, UNITED STATES· Biotechnology· Filed Jan 19, 2024

IMMUNIC, INC. reported raising capital. Based in NEW YORK, UNITED STATES. First sale reported 2024-01-04. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$80.0M
Confidence90%
Raised
$80.0M
Investors
19
Jurisdiction
DELAWARE

On the record

Location
NEW YORK, UNITED STATES
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$80.0M
Target amount
$240.0M
Filing date
Jan 19, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
19
Includes non-accredited investors
No
Revenue range
No Revenues
Total offering amount
$240.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 80,000,016 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jan 19, 2024. Details beyond the filing have not been verified.

Tags

UNITED-STATESCompanyBiotechnology$10M – $100MCompany Raise

Are you associated with IMMUNIC, INC.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record